TgPRELID, a Mitochondrial Protein Linked to Multidrug Resistance in the Parasite Toxoplasma gondii

New drugs to control infection with the protozoan parasite Toxoplasma gondii are needed as current treatments exert toxic side effects on patients. Approaches to develop novel compounds for drug development include screening of compound libraries and targeted inhibition of essential cellular pathway...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:mSphere
Egile Nagusiak: Jeffers, Victoria, Kamau, Edwin T., Srinivasan, Ananth R., Harper, Jonathan, Sankaran, Preethi, Post, Sarah E., Varberg, Joseph M., Sullivan, William J., Boyle, Jon P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288566/
https://ncbi.nlm.nih.gov/pubmed/28168222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mSphere.00229-16
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak